Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-09-26

AUTHORS

Tae Won Kwak, Do Hyung Kim, Young-Il Jeong, Dae Hwan Kang

ABSTRACT

BackgroundThe aim of this study is to evaluate the anticancer activity of vorinostat-incorporated nanoparticles (vorinostat-NPs) against HuCC-T1 human cholangiocarcinoma cells. Vorinostat-NPs were fabricated by a nanoprecipitation method using poly(dl-lactide-co-glycolide)/poly(ethylene glycol) copolymer.ResultsVorinostat-NPs exhibited spherical shapes with sizes <100 nm. Vorinostat-NPs have anticancer activity similar to that of vorinostat in vitro. Vorinostat-NPs as well as vorinostat itself increased acetylation of histone-H3. Furthermore, vorinostat-NPs have similar effectiveness in the suppression or expression of histone deacetylase, mutant type p53, p21, and PARP/cleaved caspase-3. However, vorinostat-NPs showed improved antitumor activity against HuCC-T1 cancer cell-bearing mice compared to vorinostat, whereas empty nanoparticles had no effect on tumor growth. Furthermore, vorinostat-NPs increased the expression of acetylated histone H3 in tumor tissue and suppressed histone deacetylase (HDAC) expression in vivo. The improved antitumor activity of vorinostat-NPs can be explained by molecular imaging studies using near-infrared (NIR) dye-incorporated nanoparticles, i.e. NIR-dye-incorporated nanoparticles were intensively accumulated in the tumor region rather than normal one.ConclusionsOur results demonstrate that vorinostat and vorinostat-NPs exert anticancer activity against HuCC-T1 cholangiocarcinoma cells by specific inhibition of HDAC expression. Thus, we suggest that vorinostat-NPs are a promising candidate for anticancer chemotherapy in cholangiocarcinoma.Graphical abstractLocal delivery strategy of vorinostat-NPs against cholangiocarcinomas. More... »

PAGES

60

References to SciGraph publications

  • 2010-11-30. Radiotherapy and Chemotherapy as Therapeutic Strategies in Extrahepatic Biliary Duct Carcinoma in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2010-11-02. Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase in BRITISH JOURNAL OF CANCER
  • 2011-06-03. SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis in CELL DEATH & DIFFERENTIATION
  • 2010-10-30. Outcomes from Combined Chemoradiotherapy in Unresectable and Locally Advanced Resected Cholangiocarcinoma in JOURNAL OF GASTROINTESTINAL CANCER
  • 2012-01-11. Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trial in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2007-08-13. Histone deacetylase inhibitors: molecular mechanisms of action in ONCOGENE
  • 2000-12-22. Mechanisms of suberoylanilide hydroxamic acid inhibition of mammary cell growth in BREAST CANCER RESEARCH
  • 2011-12-27. Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo in BREAST CANCER RESEARCH AND TREATMENT
  • 2012-03-05. Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8 in ONCOGENE
  • 2006-12-12. Cancer biology: mechanism of antitumour action of vorinostat (suberoylanilide hydroxamic acid), a novel histone deacetylase inhibitor in BRITISH JOURNAL OF CANCER
  • 2011-07-13. Down-Regulated Expression of HSP70 in Correlation with Clinicopathology of Cholangiocarcinoma in PATHOLOGY & ONCOLOGY RESEARCH
  • 2012-01-20. SAHA Inhibits the Growth of Colon Tumors by Decreasing Histone Deacetylase and the Expression of Cyclin D1 and Survivin in PATHOLOGY & ONCOLOGY RESEARCH
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/s12951-015-0122-4

    DOI

    http://dx.doi.org/10.1186/s12951-015-0122-4

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1009018247

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/26410576


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/10", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Technology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Blotting, Western", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cholangiocarcinoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Fluorescence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hydroxamic Acids", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunohistochemistry", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Nanoparticles", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Particle Size", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Vorinostat", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "X-Ray Diffraction", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Xenograft Model Antitumor Assays", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, 602-739, Busan, Republic of Korea", 
              "id": "http://www.grid.ac/institutes/grid.412588.2", 
              "name": [
                "Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, 602-739, Busan, Republic of Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kwak", 
            "givenName": "Tae Won", 
            "id": "sg:person.0670144177.63", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670144177.63"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "School of Medicine, Pusan National University, 626-770, Yangsan, Gyeongnam, Republic of Korea", 
              "id": "http://www.grid.ac/institutes/grid.262229.f", 
              "name": [
                "School of Medicine, Pusan National University, 626-770, Yangsan, Gyeongnam, Republic of Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kim", 
            "givenName": "Do Hyung", 
            "id": "sg:person.0711160244.15", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711160244.15"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, 602-739, Busan, Republic of Korea", 
              "id": "http://www.grid.ac/institutes/grid.412588.2", 
              "name": [
                "Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, 602-739, Busan, Republic of Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jeong", 
            "givenName": "Young-Il", 
            "id": "sg:person.01246323050.48", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246323050.48"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Internal Medicine, Pusan National University Yangsan Hospital, 626-770, Yangsan, Gyeongnam, Republic of Korea", 
              "id": "http://www.grid.ac/institutes/grid.412591.a", 
              "name": [
                "Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, 602-739, Busan, Republic of Korea", 
                "Department of Internal Medicine, Pusan National University Yangsan Hospital, 626-770, Yangsan, Gyeongnam, Republic of Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kang", 
            "givenName": "Dae Hwan", 
            "id": "sg:person.01217676577.29", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217676577.29"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s10549-011-1928-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001052747", 
              "https://doi.org/10.1007/s10549-011-1928-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1210620", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039344905", 
              "https://doi.org/10.1038/sj.onc.1210620"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/cdd.2011.71", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045446987", 
              "https://doi.org/10.1038/cdd.2011.71"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/onc.2012.81", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012645003", 
              "https://doi.org/10.1038/onc.2012.81"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/bcr284", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032302644", 
              "https://doi.org/10.1186/bcr284"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6603463", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012838269", 
              "https://doi.org/10.1038/sj.bjc.6603463"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6605969", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052465461", 
              "https://doi.org/10.1038/sj.bjc.6605969"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12253-012-9499-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040939149", 
              "https://doi.org/10.1007/s12253-012-9499-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00066-010-2161-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019840869", 
              "https://doi.org/10.1007/s00066-010-2161-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10147-011-0348-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032746045", 
              "https://doi.org/10.1007/s10147-011-0348-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12253-011-9432-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037196546", 
              "https://doi.org/10.1007/s12253-011-9432-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12029-010-9213-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031418211", 
              "https://doi.org/10.1007/s12029-010-9213-5"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2015-09-26", 
        "datePublishedReg": "2015-09-26", 
        "description": "BackgroundThe aim of this study\n is to evaluate the anticancer activity of vorinostat-incorporated nanoparticles (vorinostat-NPs) against HuCC-T1 human cholangiocarcinoma cells. Vorinostat-NPs were fabricated by a nanoprecipitation method using poly(dl-lactide-co-glycolide)/poly(ethylene glycol) copolymer.ResultsVorinostat-NPs exhibited spherical shapes with sizes <100\u00a0nm. Vorinostat-NPs have anticancer activity similar to that of vorinostat in vitro. Vorinostat-NPs as well as vorinostat itself increased acetylation of histone-H3. Furthermore, vorinostat-NPs have similar effectiveness in the suppression or expression of histone deacetylase, mutant type p53, p21, and PARP/cleaved caspase-3. However, vorinostat-NPs showed improved antitumor activity against HuCC-T1 cancer cell-bearing mice compared to vorinostat, whereas empty nanoparticles had no effect on tumor growth. Furthermore, vorinostat-NPs increased the expression of acetylated histone H3 in tumor tissue and suppressed histone deacetylase (HDAC) expression in vivo. The improved antitumor activity of vorinostat-NPs can be explained by molecular imaging studies using near-infrared (NIR) dye-incorporated nanoparticles, i.e. NIR-dye-incorporated nanoparticles were intensively accumulated in the tumor region rather than normal one.ConclusionsOur results demonstrate that vorinostat and vorinostat-NPs exert anticancer activity against HuCC-T1 cholangiocarcinoma cells by specific inhibition of HDAC expression. Thus, we suggest that vorinostat-NPs are a promising candidate for anticancer chemotherapy in cholangiocarcinoma.Graphical abstractLocal delivery strategy of vorinostat-NPs against cholangiocarcinomas.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/s12951-015-0122-4", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1031280", 
            "issn": [
              "1477-3155"
            ], 
            "name": "Journal of Nanobiotechnology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "13"
          }
        ], 
        "keywords": [
          "human cholangiocarcinoma cells", 
          "improved antitumor activity", 
          "cholangiocarcinoma cells", 
          "antitumor activity", 
          "histone deacetylase expression", 
          "anticancer activity", 
          "cell-bearing mice", 
          "exerts anticancer activity", 
          "mutant-type p53", 
          "HuCC-T1 human cholangiocarcinoma cells", 
          "molecular imaging studies", 
          "HDAC expression", 
          "tumor growth", 
          "tumor tissue", 
          "imaging studies", 
          "vorinostat", 
          "anticancer chemotherapy", 
          "similar effectiveness", 
          "acetylated histone H3", 
          "ConclusionsOur results", 
          "caspase-3", 
          "histone deacetylase", 
          "cholangiocarcinoma", 
          "specific inhibition", 
          "delivery strategies", 
          "type p53", 
          "tumor region", 
          "empty nanoparticles", 
          "cells", 
          "expression", 
          "HuCC-T1 cholangiocarcinoma cells", 
          "histone H3", 
          "chemotherapy", 
          "activity", 
          "mice", 
          "p53", 
          "vivo", 
          "inhibition", 
          "tissue", 
          "study", 
          "deacetylase", 
          "p21", 
          "aim", 
          "suppression", 
          "nanoprecipitation method", 
          "acetylation", 
          "effect", 
          "candidates", 
          "strategies", 
          "promising candidate", 
          "effectiveness", 
          "H3", 
          "results", 
          "growth", 
          "region", 
          "size", 
          "method", 
          "spherical shape", 
          "nanoparticles", 
          "shape", 
          "copolymers"
        ], 
        "name": "Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells", 
        "pagination": "60", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1009018247"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/s12951-015-0122-4"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "26410576"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/s12951-015-0122-4", 
          "https://app.dimensions.ai/details/publication/pub.1009018247"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-06-01T22:12", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_656.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/s12951-015-0122-4"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12951-015-0122-4'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12951-015-0122-4'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12951-015-0122-4'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12951-015-0122-4'


     

    This table displays all metadata directly associated to this object as RDF triples.

    254 TRIPLES      22 PREDICATES      113 URIs      94 LITERALS      22 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/s12951-015-0122-4 schema:about N0abb1781a2bf48aa8485f913d8c2ceb9
    2 N13e8681b8d684f20a2a0165259da7593
    3 N1925b9f56cc44ced85ce8d141e450f69
    4 N30631d0cd46b40359ec5556943d9bdb6
    5 N3c733319dd34438dab5b68bea5c2f5ec
    6 N4ecc9cc30dae49429ab48f0adb5cc927
    7 N633cb69702084f45afc299db043a0dac
    8 N678338dc490349cba15194976fad8f1e
    9 N67e4bc7fb71b4c8597f98680ae6c8384
    10 Nad13ad2da36f4e69a8f8728bbdf3072e
    11 Nb48c69b14b0c4fb69c3df4d8be8900e3
    12 Nbefce53a12264b35b2872f14b103c173
    13 Ne41de1b21e6e4ebc8f0b6f14d15653c0
    14 Nefd26f4ea6ee45eda0f0d8d6a61538c2
    15 Nf341d5ec030d497a8c181df84c629271
    16 anzsrc-for:10
    17 schema:author N90d34aa7b1ff49b1b4967b9b90dd66ef
    18 schema:citation sg:pub.10.1007/s00066-010-2161-y
    19 sg:pub.10.1007/s10147-011-0348-6
    20 sg:pub.10.1007/s10549-011-1928-x
    21 sg:pub.10.1007/s12029-010-9213-5
    22 sg:pub.10.1007/s12253-011-9432-5
    23 sg:pub.10.1007/s12253-012-9499-7
    24 sg:pub.10.1038/cdd.2011.71
    25 sg:pub.10.1038/onc.2012.81
    26 sg:pub.10.1038/sj.bjc.6603463
    27 sg:pub.10.1038/sj.bjc.6605969
    28 sg:pub.10.1038/sj.onc.1210620
    29 sg:pub.10.1186/bcr284
    30 schema:datePublished 2015-09-26
    31 schema:datePublishedReg 2015-09-26
    32 schema:description BackgroundThe aim of this study is to evaluate the anticancer activity of vorinostat-incorporated nanoparticles (vorinostat-NPs) against HuCC-T1 human cholangiocarcinoma cells. Vorinostat-NPs were fabricated by a nanoprecipitation method using poly(dl-lactide-co-glycolide)/poly(ethylene glycol) copolymer.ResultsVorinostat-NPs exhibited spherical shapes with sizes <100 nm. Vorinostat-NPs have anticancer activity similar to that of vorinostat in vitro. Vorinostat-NPs as well as vorinostat itself increased acetylation of histone-H3. Furthermore, vorinostat-NPs have similar effectiveness in the suppression or expression of histone deacetylase, mutant type p53, p21, and PARP/cleaved caspase-3. However, vorinostat-NPs showed improved antitumor activity against HuCC-T1 cancer cell-bearing mice compared to vorinostat, whereas empty nanoparticles had no effect on tumor growth. Furthermore, vorinostat-NPs increased the expression of acetylated histone H3 in tumor tissue and suppressed histone deacetylase (HDAC) expression in vivo. The improved antitumor activity of vorinostat-NPs can be explained by molecular imaging studies using near-infrared (NIR) dye-incorporated nanoparticles, i.e. NIR-dye-incorporated nanoparticles were intensively accumulated in the tumor region rather than normal one.ConclusionsOur results demonstrate that vorinostat and vorinostat-NPs exert anticancer activity against HuCC-T1 cholangiocarcinoma cells by specific inhibition of HDAC expression. Thus, we suggest that vorinostat-NPs are a promising candidate for anticancer chemotherapy in cholangiocarcinoma.Graphical abstractLocal delivery strategy of vorinostat-NPs against cholangiocarcinomas.
    33 schema:genre article
    34 schema:inLanguage en
    35 schema:isAccessibleForFree true
    36 schema:isPartOf N12dd384df3404239ae82c0f19122bb62
    37 N14a9d21f3c20402899544b72543b472c
    38 sg:journal.1031280
    39 schema:keywords ConclusionsOur results
    40 H3
    41 HDAC expression
    42 HuCC-T1 cholangiocarcinoma cells
    43 HuCC-T1 human cholangiocarcinoma cells
    44 acetylated histone H3
    45 acetylation
    46 activity
    47 aim
    48 anticancer activity
    49 anticancer chemotherapy
    50 antitumor activity
    51 candidates
    52 caspase-3
    53 cell-bearing mice
    54 cells
    55 chemotherapy
    56 cholangiocarcinoma
    57 cholangiocarcinoma cells
    58 copolymers
    59 deacetylase
    60 delivery strategies
    61 effect
    62 effectiveness
    63 empty nanoparticles
    64 exerts anticancer activity
    65 expression
    66 growth
    67 histone H3
    68 histone deacetylase
    69 histone deacetylase expression
    70 human cholangiocarcinoma cells
    71 imaging studies
    72 improved antitumor activity
    73 inhibition
    74 method
    75 mice
    76 molecular imaging studies
    77 mutant-type p53
    78 nanoparticles
    79 nanoprecipitation method
    80 p21
    81 p53
    82 promising candidate
    83 region
    84 results
    85 shape
    86 similar effectiveness
    87 size
    88 specific inhibition
    89 spherical shape
    90 strategies
    91 study
    92 suppression
    93 tissue
    94 tumor growth
    95 tumor region
    96 tumor tissue
    97 type p53
    98 vivo
    99 vorinostat
    100 schema:name Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells
    101 schema:pagination 60
    102 schema:productId N71c8936c73884b1fba56642d68ec3715
    103 N853de997b54e4013ad07cfaae94dc096
    104 Nf44bea53bb304e6e9aa3f46c5278ecf7
    105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009018247
    106 https://doi.org/10.1186/s12951-015-0122-4
    107 schema:sdDatePublished 2022-06-01T22:12
    108 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    109 schema:sdPublisher N13353db356f54db690b48176a29b87d4
    110 schema:url https://doi.org/10.1186/s12951-015-0122-4
    111 sgo:license sg:explorer/license/
    112 sgo:sdDataset articles
    113 rdf:type schema:ScholarlyArticle
    114 N0abb1781a2bf48aa8485f913d8c2ceb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    115 schema:name Immunohistochemistry
    116 rdf:type schema:DefinedTerm
    117 N12dd384df3404239ae82c0f19122bb62 schema:volumeNumber 13
    118 rdf:type schema:PublicationVolume
    119 N13353db356f54db690b48176a29b87d4 schema:name Springer Nature - SN SciGraph project
    120 rdf:type schema:Organization
    121 N13e8681b8d684f20a2a0165259da7593 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Xenograft Model Antitumor Assays
    123 rdf:type schema:DefinedTerm
    124 N14a9d21f3c20402899544b72543b472c schema:issueNumber 1
    125 rdf:type schema:PublicationIssue
    126 N172258ad0de645229236c22cd3291695 rdf:first sg:person.0711160244.15
    127 rdf:rest Ne7662034646f47c2a00f88034fff18e2
    128 N1925b9f56cc44ced85ce8d141e450f69 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Cholangiocarcinoma
    130 rdf:type schema:DefinedTerm
    131 N30631d0cd46b40359ec5556943d9bdb6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Antineoplastic Agents
    133 rdf:type schema:DefinedTerm
    134 N3c733319dd34438dab5b68bea5c2f5ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Cell Line, Tumor
    136 rdf:type schema:DefinedTerm
    137 N4ecc9cc30dae49429ab48f0adb5cc927 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Humans
    139 rdf:type schema:DefinedTerm
    140 N5812a4f059944c33bc9957807719b83f rdf:first sg:person.01217676577.29
    141 rdf:rest rdf:nil
    142 N633cb69702084f45afc299db043a0dac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    143 schema:name Mice
    144 rdf:type schema:DefinedTerm
    145 N678338dc490349cba15194976fad8f1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    146 schema:name Animals
    147 rdf:type schema:DefinedTerm
    148 N67e4bc7fb71b4c8597f98680ae6c8384 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Blotting, Western
    150 rdf:type schema:DefinedTerm
    151 N71c8936c73884b1fba56642d68ec3715 schema:name pubmed_id
    152 schema:value 26410576
    153 rdf:type schema:PropertyValue
    154 N853de997b54e4013ad07cfaae94dc096 schema:name doi
    155 schema:value 10.1186/s12951-015-0122-4
    156 rdf:type schema:PropertyValue
    157 N90d34aa7b1ff49b1b4967b9b90dd66ef rdf:first sg:person.0670144177.63
    158 rdf:rest N172258ad0de645229236c22cd3291695
    159 Nad13ad2da36f4e69a8f8728bbdf3072e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name X-Ray Diffraction
    161 rdf:type schema:DefinedTerm
    162 Nb48c69b14b0c4fb69c3df4d8be8900e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Vorinostat
    164 rdf:type schema:DefinedTerm
    165 Nbefce53a12264b35b2872f14b103c173 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Particle Size
    167 rdf:type schema:DefinedTerm
    168 Ne41de1b21e6e4ebc8f0b6f14d15653c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Nanoparticles
    170 rdf:type schema:DefinedTerm
    171 Ne7662034646f47c2a00f88034fff18e2 rdf:first sg:person.01246323050.48
    172 rdf:rest N5812a4f059944c33bc9957807719b83f
    173 Nefd26f4ea6ee45eda0f0d8d6a61538c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Fluorescence
    175 rdf:type schema:DefinedTerm
    176 Nf341d5ec030d497a8c181df84c629271 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    177 schema:name Hydroxamic Acids
    178 rdf:type schema:DefinedTerm
    179 Nf44bea53bb304e6e9aa3f46c5278ecf7 schema:name dimensions_id
    180 schema:value pub.1009018247
    181 rdf:type schema:PropertyValue
    182 anzsrc-for:10 schema:inDefinedTermSet anzsrc-for:
    183 schema:name Technology
    184 rdf:type schema:DefinedTerm
    185 sg:journal.1031280 schema:issn 1477-3155
    186 schema:name Journal of Nanobiotechnology
    187 schema:publisher Springer Nature
    188 rdf:type schema:Periodical
    189 sg:person.01217676577.29 schema:affiliation grid-institutes:grid.412591.a
    190 schema:familyName Kang
    191 schema:givenName Dae Hwan
    192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217676577.29
    193 rdf:type schema:Person
    194 sg:person.01246323050.48 schema:affiliation grid-institutes:grid.412588.2
    195 schema:familyName Jeong
    196 schema:givenName Young-Il
    197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246323050.48
    198 rdf:type schema:Person
    199 sg:person.0670144177.63 schema:affiliation grid-institutes:grid.412588.2
    200 schema:familyName Kwak
    201 schema:givenName Tae Won
    202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670144177.63
    203 rdf:type schema:Person
    204 sg:person.0711160244.15 schema:affiliation grid-institutes:grid.262229.f
    205 schema:familyName Kim
    206 schema:givenName Do Hyung
    207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711160244.15
    208 rdf:type schema:Person
    209 sg:pub.10.1007/s00066-010-2161-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1019840869
    210 https://doi.org/10.1007/s00066-010-2161-y
    211 rdf:type schema:CreativeWork
    212 sg:pub.10.1007/s10147-011-0348-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032746045
    213 https://doi.org/10.1007/s10147-011-0348-6
    214 rdf:type schema:CreativeWork
    215 sg:pub.10.1007/s10549-011-1928-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1001052747
    216 https://doi.org/10.1007/s10549-011-1928-x
    217 rdf:type schema:CreativeWork
    218 sg:pub.10.1007/s12029-010-9213-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031418211
    219 https://doi.org/10.1007/s12029-010-9213-5
    220 rdf:type schema:CreativeWork
    221 sg:pub.10.1007/s12253-011-9432-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037196546
    222 https://doi.org/10.1007/s12253-011-9432-5
    223 rdf:type schema:CreativeWork
    224 sg:pub.10.1007/s12253-012-9499-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040939149
    225 https://doi.org/10.1007/s12253-012-9499-7
    226 rdf:type schema:CreativeWork
    227 sg:pub.10.1038/cdd.2011.71 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045446987
    228 https://doi.org/10.1038/cdd.2011.71
    229 rdf:type schema:CreativeWork
    230 sg:pub.10.1038/onc.2012.81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012645003
    231 https://doi.org/10.1038/onc.2012.81
    232 rdf:type schema:CreativeWork
    233 sg:pub.10.1038/sj.bjc.6603463 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012838269
    234 https://doi.org/10.1038/sj.bjc.6603463
    235 rdf:type schema:CreativeWork
    236 sg:pub.10.1038/sj.bjc.6605969 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052465461
    237 https://doi.org/10.1038/sj.bjc.6605969
    238 rdf:type schema:CreativeWork
    239 sg:pub.10.1038/sj.onc.1210620 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039344905
    240 https://doi.org/10.1038/sj.onc.1210620
    241 rdf:type schema:CreativeWork
    242 sg:pub.10.1186/bcr284 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032302644
    243 https://doi.org/10.1186/bcr284
    244 rdf:type schema:CreativeWork
    245 grid-institutes:grid.262229.f schema:alternateName School of Medicine, Pusan National University, 626-770, Yangsan, Gyeongnam, Republic of Korea
    246 schema:name School of Medicine, Pusan National University, 626-770, Yangsan, Gyeongnam, Republic of Korea
    247 rdf:type schema:Organization
    248 grid-institutes:grid.412588.2 schema:alternateName Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, 602-739, Busan, Republic of Korea
    249 schema:name Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, 602-739, Busan, Republic of Korea
    250 rdf:type schema:Organization
    251 grid-institutes:grid.412591.a schema:alternateName Department of Internal Medicine, Pusan National University Yangsan Hospital, 626-770, Yangsan, Gyeongnam, Republic of Korea
    252 schema:name Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, 602-739, Busan, Republic of Korea
    253 Department of Internal Medicine, Pusan National University Yangsan Hospital, 626-770, Yangsan, Gyeongnam, Republic of Korea
    254 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...